Cargando…

‘The end’ – or is it? Emergence of SARS-CoV-2 EG.5 and BA.2.86 subvariants

Detalles Bibliográficos
Autores principales:	Rahimi, Farid, Darvishi, Mohammad, Bezmin Abadi, Amin Talebi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Future Medicine Ltd 2023
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10511002/ https://www.ncbi.nlm.nih.gov/pubmed/37736262 http://dx.doi.org/10.2217/fvl-2023-0150

Ejemplares similares

Implications of the SARS-CoV-2 subvariants BA.4 and BA.5
por: Rahimi, Farid, et al.
Publicado: (2022)

The Omicron subvariant BA.2: Birth of a new challenge during the COVID-19 pandemic
por: Rahimi, Farid, et al.
Publicado: (2022)

Emergence of the Omicron SARS-CoV-2 subvariants during the COVID-19 pandemic
por: Rahimi, Farid, et al.
Publicado: (2022)

Detection of the XE subvariant of SARS-CoV-2: A perspective
por: Rahimi, Farid, et al.
Publicado: (2022)

SARS-CoV-2 Omicron subvariant BA.2.86: limited potential for global spread
por: Wang, Xinling, et al.
Publicado: (2023)

SARS-CoV-2 Lambda (C.37): An emerging variant of concern?
por: Darvishi, Mohammad, et al.
Publicado: (2021)

Highly contagious but less severe COVID-19 caused by new SARS-CoV-2 sublineages may abate the pandemic
por: Rahimi, Farid, et al.
Publicado: (2022)

Emergence of the Delta Plus variant of SARS-CoV-2 in Iran
por: Rahimi, Farid, et al.
Publicado: (2021)

Implications of the Emergence of a New Variant of SARS-CoV-2, VUI-202012/01
por: Rahimi, Farid, et al.
Publicado: (2021)

A Commentary on “Omicron SARS-CoV-2 variant: Reasons of emergence and lessons learnt” (Int J Surg 2022;97:106198) Contact-tracing and global vaccine equity: Crucial responses to emergence of the Omicron SARS-CoV-2 variant
por: Rahimi, Farid, et al.
Publicado: (2022)

Hybrid SARS-CoV-2 variants
por: Rahimi, Farid, et al.
Publicado: (2022)

First cases of SARS-CoV-2 BA.2.86 in Denmark, 2023
por: Rasmussen, Morten, et al.
Publicado: (2023)

Challenges of managing the asymptomatic carriers of SARS-CoV-2
por: Rahimi, Farid, et al.
Publicado: (2020)

Is Omicron the last SARS-CoV-2 Variant of Concern?
por: Rahimi, Farid, et al.
Publicado: (2022)

Omicron: A highly transmissible SARS-CoV-2 variant
por: Rahimi, Farid, et al.
Publicado: (2022)

Case-finding: Fast, Available, and Efficient Font-line Diagnostics for SARS-CoV-2
por: Rahimi, Farid, et al.
Publicado: (2020)

The third booster vaccination dose against COVID-19: indication for circulating SARS-CoV-2 variants
por: Rahimi, Farid, et al.
Publicado: (2021)

SARS-CoV-2 BA.2.86 (“Pirola”): Is it Pi or Just Another Omicron Sublineage?
por: Focosi, Daniele, et al.
Publicado: (2023)

Corrigendum to ‘Case-finding: Fast, Available, and Efficient Font-line Diagnostics for SARS-CoV-2’[Arch. Med. Res. 51(5) (2020) 453–454/ARCMED 2020 432]
por: Rahimi, Farid, et al.
Publicado: (2023)

Immune Evasion, Infectivity, and Fusogenicity of SARS-CoV-2 Omicron BA.2.86 and FLip Variants
por: Qu, Panke, et al.
Publicado: (2023)

Early Detection and Surveillance of the SARS-CoV-2 Variant BA.2.86 — Worldwide, July–October 2023
por: Lambrou, Anastasia S., et al.
Publicado: (2023)

Less neutralization evasion of SARS-CoV-2 BA.2.86 than XBB sublineages and CH.1.1
por: Hu, Yanping, et al.
Publicado: (2023)

Practical Strategies Against the Novel Coronavirus and COVID-19—the Imminent Global Threat
por: Rahimi, Farid, et al.
Publicado: (2020)

Comment on “circSMARCA5 Functions as a Diagnostic and Prognostic Biomarker for Gastric Cancer”
por: Rahimi, Farid, et al.
Publicado: (2019)

Tackling the COVID-19 Pandemic
por: Rahimi, Farid, et al.
Publicado: (2020)

Transparency and information sharing could help abate the COVID-19 pandemic
por: Rahimi, Farid, et al.
Publicado: (2020)

WHO prequalified tocilizumab and vaccine boosters against COVID-19
por: Rahimi, Farid, et al.
Publicado: (2022)

The Ukrainian refugee crisis and the COVID-19 pandemic in Europe
por: Rahimi, Farid, et al.
Publicado: (2022)

COVID-19 and science diplomacy
por: Rahimi, Farid, et al.
Publicado: (2022)

The 2022 monkeypox outbreak: Lessons from the 640 cases in 36 countries
por: Rahimi, Farid, et al.
Publicado: (2022)

Identification of Streptococcus gallolyticus in tumor samples of Iranian patients diagnosed with colorectal cancer
por: Kamali, Negin, et al.
Publicado: (2022)

The Mu strain: the last but not least circulating ‘variant of interest’ potentially affecting the COVID-19 pandemic
por: Rahimi, Farid, et al.
Publicado: (2021)

Immediate countermeasures against the monkeypox outbreak
por: Rahimi, Farid, et al.
Publicado: (2022)

High attack rate in a large care home outbreak of SARS-CoV-2 BA.2.86, East of England, August 2023
por: Reeve, Lucy, et al.
Publicado: (2023)

Helicobacter pylori: Emergence of a Superbug
por: Talebi Bezmin Abadi, Amin
Publicado: (2014)

Further humoral immunity evasion of emerging SARS-CoV-2 BA.4 and BA.5 subvariants
por: Jian, Fanchong, et al.
Publicado: (2022)

Commentary on ‘Implications of the SARS-CoV-2 subvariants BA.4 and BA.5’
por: Khani, Elnaz, et al.
Publicado: (2023)

2.86 The Impact of COVID-19 on School Mental Health Services
por: Rogers, Kenneth M.
Publicado: (2022)

Early detection of the emerging SARS-CoV-2 BA.2.86 lineage through integrated genomic surveillance of wastewater and COVID-19 cases in Sweden, weeks 31 to 38 2023
por: Espinosa-Gongora, Carmen, et al.
Publicado: (2023)

Comparable neutralisation evasion of SARS-CoV-2 omicron subvariants BA.1, BA.2, and BA.3
por: Arora, Prerna, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ni8m7m2s9sbf6j0odhu4jcbslo